August 13, 2024

‘The Whole World Is In Overdose,’ Says CEO Of SyqeAir About the Groundbreaking Cannabis Inhaler

An article on Benzinga highlighting the innovative SyqeAir Inhaler and its role in addressing the global challenge of cannabis overdose through metered dosing. Read what the CEO of SyqeAir, Hagit Kamin, had to say about this.

Unique Cannabis Inhaler Gives Israeli Patients a New Lease on Life

Syqe®’s groundbreaking SyqeAir Inhaler is revolutionizing medical cannabis treatment. Thus argues The Jerusalem Post, which discusses the significant impact of Syqe®’s technology on treating chronic pain and PTSD patients.

How Israel’s Weed Tech Industry Is Taking On America’s Opioid Crisis

10/07/2018

America is beginning to see cannabis as an alternative to prescription pills. Israel is years ahead – and its entrepreneurs want to curb a crisis of opioid addiction that is completely out of control.

Novachem offers metered-dosing inhaler to Australian patients

21/12/2022

A metered-dose inhaler is being distributed by Novachem in Australia. Syqe® Medical, the Israeli MedTech company behind the technology claims it will “revolutionize” the delivery of medicinal cannabis.

Syqe® Begins Marketing Medical Cannabis Inhaler

20/06/2019

The new inhaler, which allows doctors to prescribe precise dosages, has received Ministry of Health approval in Israel.

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.

Day: August 13, 2024

‘The Whole World Is In Overdose,’ Says CEO Of SyqeAir About the Groundbreaking Cannabis Inhaler

Unique Cannabis Inhaler Gives Israeli Patients a New Lease on Life

Related Posts

How Israel’s Weed Tech Industry Is Taking On America’s Opioid Crisis

Novachem offers metered-dosing inhaler to Australian patients

Syqe® Begins Marketing Medical Cannabis Inhaler